Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 11.77
-0.34 (-2.81%)
At close: May 27, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.86 billion as of May 27, 2026. Its market cap has decreased by -0.54% in one year.
Market Cap
2.86B
Enterprise Value
3.35B
Revenue
1.52B
Ranking
n/a
PE Ratio
15.76
Stock Price
11.77
Market Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.86B, an increase of 4,526.75%. That is a compound annual growth rate of 17.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 2.94B | -9.54% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Albert David | 4.12B |
| Medico Remedies | 3.99B |
| Medicamen Biotech | 3.60B |
| Trident Lifeline | 2.98B |
| Sat Kartar Life | 2.96B |
| Kerala Ayurveda | 2.64B |
| Everest Organics | 2.62B |
| Ambalal Sarabhai Enterprises | 2.48B |